As of Nov 24
| +1.65 / +1.99%|
The 5 analysts offering 12-month price forecasts for GW Pharmaceuticals PLC have a median target of 147.00, with a high estimate of 150.00 and a low estimate of 135.00. The median estimate represents a +73.92% increase from the last price of 84.52.
The current consensus among 5 polled investment analysts is to Buy stock in GW Pharmaceuticals PLC. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.